Revenue: The sum of all revenue fields included for a company's operating activities.
Avalo Therapeutics, Inc. (AVTX) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-13.15M |
|
-- |
|
-- |
|
$14.67M |
|
$-14.67M |
|
$1.53M |
|
$-13.14M |
|
$-13.14M |
|
$-13.15M |
|
$-13.15M |
|
$-13.15M |
|
$-13.15M |
|
$-14.67M |
|
$-14.53M |
|
10.51M |
|
10.51M |
|
$-1.25 |
|
$-1.25 |
|
| Balance Sheet Financials | |
$126.94M |
|
$0.95M |
|
$11.58M |
|
$138.52M |
|
$5.62M |
|
-- |
|
$10.29M |
|
$15.91M |
|
$122.61M |
|
$112.11M |
|
$122.61M |
|
10.83M |
|
| Cash Flow Statement Financials | |
$-9.46M |
|
-- |
|
-- |
|
$134.70M |
|
$125.24M |
|
$-9.46M |
|
$3.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.46M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.72% |
|
-11.73% |
|
-9.49% |
|
-10.72% |
|
$11.32 |
|
$-0.90 |
|
$-0.90 |
|